2010
DOI: 10.1007/10_2010_92
|View full text |Cite
|
Sign up to set email alerts
|

Engineering Liposomes and Nanoparticles for Biological Targeting

Abstract: Our ability to engineer nanomaterials for biological and medical applications is continuously increasing, and nanomaterial designs are becoming more and more complex. One very good example of this is the drug delivery field where nanoparticle systems can be used to deliver drugs specifically to diseased tissue. In the early days, the design of the nanoparticles was relatively simple, but today we can surface functionalize and manipulate material properties to target diseased tissue and build highly complex dru… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
48
0
2

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 46 publications
(50 citation statements)
references
References 137 publications
0
48
0
2
Order By: Relevance
“…The various surface functionalization chemistries that can be used for nanoparticles are well-described in other reviews. 181,184,185 …”
Section: Targetingmentioning
confidence: 99%
“…The various surface functionalization chemistries that can be used for nanoparticles are well-described in other reviews. 181,184,185 …”
Section: Targetingmentioning
confidence: 99%
“…6 A number of nanoparticle-based pH-sensitive drug delivery systems are being reported every year where various surface ligands, e.g., folate and antibodies, are attached to the surface of nanoparticles for targeting overexpressed receptors. 6,7 However, there is very limited knowledge on the intracellular trafficking of these systems, particularly regarding the pH that the particles are experiencing after internalization. At present, it is just assumed that the pHsensitive drug delivery system ends up in acidic compartments, but this has not been tested, and it is reasonable to hypothesize that the targeting ligands used could have an effect on trafficking.…”
mentioning
confidence: 99%
“…The product was purified directly by column chromatography (95:5 CH 2 Cl 2 /MeOH) to yield the product as a colorless oil (114 mg, 73%). Analytical data: 1 extruding at least 20 times using a Lipex™ Extruder (Northern Lipids, Burnaby, BC, Canada) through polycarbonate membranes with a final pore size of 100 nm (Nuclepore, Pleasanton, CA, USA). Liposomes were then incubated with 5-TAMRA-PEG3-Azide (Baseclick, Tutzing, Germany) in methanol in a 10:1 ratio of BCN-lipid:azide unless stated otherwise (this 10:1 ratio is corrected for the amount of BCN-lipid facing the inside of the liposome and as such is not available for coupling).…”
Section: Chemicalsmentioning
confidence: 99%
“…The common strategy is to synthesize a new lipid that contains a reactive group that can react with a complementary reactive group on the ligand. Many different chemistries have been explored for surface modification [1]. Ideally, these reactions should be fast and specific and reaction conditions should be mild enough not to cause damage to the lipid membrane or to the ligand.…”
Section: Introductionmentioning
confidence: 99%